Also known as: Palmitoyl Pentapeptide-4
The original palmitoylated matrikine peptide. Largest clinical study in the Cluster G group — 93 women, 6 months, retinol comparator. Distinct from Matrixyl 3000.
📖 Read the full Matrixyl research overview →
Evidence Tier: Tier 3 — Pilot / Limited Human Data · Peptidings Verdict: Reasonable Bet